4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol

Star0

DB08770ExperimentalSmall molecule

4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol: Overview.

Mechanism: Pharmacologically active on Adenosine receptor A2a
Curator reviewed
Formula / weight: C₁₆H₁₅N₇O₂ · 337.336 g/mol (avg)

Resolves to

Compound

UNII5NIC36BO71ChEMBLCHEMBL113142ChEBI92361PubChem176407

Structure

InChIKeyPWTBZOIUWZOPFT-UHFFFAOYSA-NSMILESNC1=NC(NCCC2=CC=C(O)C=C2)=NC2=NC(=NN12)C1=CC=CO1

Targets

P29274ADORA2AP29275ADORA2BP30542ADORA1

What you can answer from here — as of April 02, 2025

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

13+ReferencesStructured and connected to the statements they support

Which drugs share a target with 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account